Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326286 · ClinicalTrials.gov registry record
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 3,265
- Enrollment target
NCT01326286 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 3,265 participants.
The verdict
NCT01326286 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 3,265 participants
- Enrollment target
Study Summary
This study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer. It will focus on modern technologies and control for differences in patients and treatments that may affect both cancer-related and patient-reported outcomes (such as impotence and incontinence). By figuring out what treatments "work best, in which patients and in whose hands", it will help men with prostate cancer make better decisions regarding their care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,265 participants |
| Start Date | 2011-03 |
| Est. Completion | 2018-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01326286
The ClinicalTrials.gov registry entry for NCT01326286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01326286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01326286 about?
NCT01326286 is a clinical study titled "Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer". This study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer. It will focus on modern technologies and control for differences in patients and treatments that may affect both cancer-related and patient-reported outcomes (such...
What is the current status of trial NCT01326286?
This trial is currently completed. The enrollment target is 3,265 participants. The study started on 2011-03. Estimated completion is 2018-09.
Who is sponsoring clinical trial NCT01326286?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.